| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.29 | 2e-17 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.29 | 1e-13 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-11 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-11 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-09 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-09 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-09 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-09 |